Clinical trials recruiting for Advanced Solid Malignancies
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| AZD9574 | 1 |
| BMS-986523 | 1 |
| Cetuximab | 1 |
| Datopotamab Deruxtecan (Dato-DXd) | 1 |
| Gemcitabine | 1 |
| Nab-paclitaxel | 1 |
| Pembrolizumab | 1 |
| Temozolomide (TMZ) | 1 |
| [11C]AZ1419 3391 | 1 |
| trastuzumab deruxtecan (T-DXd) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 2 |
| Virginia | 2 |
| California | 1 |
| Illinois | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| New York | 1 |
| Oregon | 1 |
| Utah | 1 |
Top cities
Self-screener
Recruiting trials
- A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Related conditions
Trials recruiting for Advanced Solid Malignancies often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Advanced Solid Malignancies trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.